EEF1A2 and breast carcinoma: Analyzing EEF1A2 levels through immunohistochemistry on a breast cancer tissue microarray, they found that while normal breast tissue displayed minimal or no presence of EEF1A2 protein, strong and moderate EEF1A2 expression was evident in 11% and 48% of the tumor samples, respectively [34].